These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35816948)

  • 1. Carotid intima media as predictor of liver fibrosis in type 2 diabetes mellitus with NAFLD.
    Shabbirhussain BV; Singh S; Dixit VK; Verma A; Singh SK
    Diabetes Metab Syndr; 2022 Jul; 16(7):102560. PubMed ID: 35816948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.
    Bhatia L; Scorletti E; Curzen N; Clough GF; Calder PC; Byrne CD
    Atherosclerosis; 2016 Mar; 246():13-20. PubMed ID: 26748347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.
    Wang C; Cai Z; Deng X; Li H; Zhao Z; Guo C; Zhang P; Li L; Gu T; Yang L; Zhao L; Wang D; Yuan G
    Int J Med Sci; 2021; 18(14):3280-3289. PubMed ID: 34400897
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation Between Carotid Intima Media Thickness and Non-Alcoholic Fatty Liver Disease.
    Kumari S; Porwal YC; Gupta R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease: a population-based case-control study.
    Lankarani KB; Mahmoodi M; Lotfi M; Zamiri N; Heydari ST; Ghaffarpasand F; Fallahzadeh MK; Babaeinejad M; Maharlouei N; Mirzaee O; Geramizadeh B; Peymani P
    Korean J Gastroenterol; 2013 Dec; 62(6):344-51. PubMed ID: 24365733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between nonalcoholic fatty liver disease and carotid intima-media thickness.
    Vu H; Khanh Tuong TT; Hoang Lan N; Quoc Thang T; Bilgin K; Hoa T; Minh Duc N; The Dung B
    Clin Ter; 2023; 174(1):42-47. PubMed ID: 36655643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease.
    Vanjiappan S; Hamide A; Ananthakrishnan R; Periyasamy SG; Mehalingam V
    Diabetes Metab Syndr; 2018 Jul; 12(4):479-482. PubMed ID: 29402657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease.
    Arai T; Atsukawa M; Tsubota A; Kato K; Abe H; Ono H; Kawano T; Yoshida Y; Tanabe T; Okubo T; Hayama K; Nakagawa-Iwashita A; Itokawa N; Kondo C; Kaneko K; Emoto N; Nagao M; Inagaki K; Fukuda I; Sugihara H; Iwakiri K
    Sci Rep; 2021 Aug; 11(1):15938. PubMed ID: 34354193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of cardiometabolic risk factors and their association with carotid intima media thickness among patients with type 2 diabetes mellitus-single center experience in a developing country.
    Weerarathna TP; Lekamwasam S; Kodikara I; Wasana KGP; Fonseka L
    Turk J Med Sci; 2024; 54(3):545-554. PubMed ID: 39050007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between non-alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community.
    Tan EC; Tai MS; Chan WK; Mahadeva S
    JGH Open; 2019 Apr; 3(2):117-125. PubMed ID: 31061886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications.
    Cheng YM; Wang CC; Kao JH
    Hepatol Int; 2023 Apr; 17(2):350-356. PubMed ID: 36471232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Study of Correlation between Non Alcoholic Fatty Liver Disease and Carotid Atherosclerosis.
    Sagar A; L R; Farheen SA
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score.
    Xin Z; Zhu Y; Wang S; Liu S; Xu M; Wang T; Lu J; Chen Y; Zhao Z; Wang W; Ning G; Bi Y; Xu Y; Li M
    Liver Int; 2020 Apr; 40(4):806-814. PubMed ID: 31820847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease.
    Tsai PS; Cheng YM; Wang CC; Kao JH
    Eur J Gastroenterol Hepatol; 2023 Nov; 35(11):1278-1283. PubMed ID: 37773778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a non-invasive model in predicting the cardiovascular morbidity and histological severity in non-alcoholic fatty liver disease.
    Hanafy AS; Seleem WM; El-Kalla F; AbdAlkhalik Basha M; Abd-Elsalam S
    Diabetes Metab Syndr; 2019; 13(3):2272-2278. PubMed ID: 31235168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.
    Fracanzani AL; Tiraboschi S; Pisano G; Consonni D; Baragetti A; Bertelli C; Norata D; Valenti L; Grigore L; Porzio M; Catapano A; Fargion S
    Atherosclerosis; 2016 Mar; 246():208-13. PubMed ID: 26803429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroscan and low-density lipoprotein as determinants of severe liver fibrosis in diabetic patients with nonalcoholic fatty liver disease.
    Jaafar RF; Hajj Ali AM; Zaghal AM; Kanso M; Habib SG; Halaoui AF; Daniel F; Mokaddem F; Khalife MJ; Mukherji DM; Faraj WG
    Eur J Gastroenterol Hepatol; 2019 Dec; 31(12):1540-1544. PubMed ID: 31135513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.
    Ampuero J; Aller R; Gallego-Durán R; Crespo J; Calleja JL; García-Monzón C; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Albillos A; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Guerra MH; Augustín S; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero Gómez M;
    J Hepatol; 2020 Jul; 73(1):17-25. PubMed ID: 32147361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.